-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster II

Symposia: Emerging Tools, Techniques, and Artificial Intelligence in Hematology Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Christopher M. M Sauer, MD, PhD, MPH1,2*, Till Rostalski, MD2*, Jens Kleesiek, MD PhD2*, Hans Christian Reinhardt, MD3, Felix Nensa, MD2* and Gernot Pucher, MSc1,2*

1Department of Hematology & Stem Cell Transplantation, University Hospital Essen, Essen, Germany
2Institute for AI in Medicine, University Hospital Essen, Essen, Germany
3Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Manuel Piñeiro Fiel1,2*, Carlos Pérez Míguez2,3*, Jose Antonio Taibo Salorio4*, Davide Crucitti1,2*, Jesús Gómez Fernández1,2*, Noelia Jorge Ríos3,5*, Rosanna Abal García3,5*, Jose Angel Diaz Arias3,6*, Carlos Aliste Santos7*, Máximo Francisco Fraga Rodríguez8* and Adrian Mosquera Orgueira, MD, PhD3,9*

1Computational Hematology & Genomics Group (GrHeCo-Xen), Health Research Institute of Santiago de Compostela (IDIS), Spain, Santiago de Compostela, Spain
2University Hospital of Santiago de Compostela, Department of Hematology, Santiago de Compostela, Spain, Santiago de Compostela, Spain
3Computational Hematology & Genomics Group (GrHeCo-Xen), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
4EDISA, Ourense, Spain
5University Hospital of Santiago de Compostela, Department of Hematology, Santiago de Compostela, Spain
6University Hospital of Santiago de Compostela, Department of Hematology, IDIS, A Coruña, Spain
7Department of Pathology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain
8University Hospital of Santiago de Compostela, Department of Pathology, Santiago de Compostela, Spain
9University Hospital of Santiago de Compostela, Department of Hematology, IDIS, SANTIAGO DE COMPOSTELA, Spain

Yalan Yu1*, Yuzhe Pan2*, Shuang Peng2*, Wanyue Yin1*, Hui Shen1*, Jing He1* and Fuling Zhou, PhD3

1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China
2School of Nursing, Wuhan University, Wuhan, China
3Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China

Jiaqi Chen, PhD1,2*, Qihui Chen3*, Huan Hu, PhD4*, Fang Wang, MD5*, Xue Chen, MD6*, Yang Zhang, MD5*, Xiaoli Ma, MD5*, Panxiang Cao6*, Yu Li6*, Xiaosu Zhou, PhD7*, Mingyue Liu6* and Hongxing Liu, MD6,8,9,10

1Pathology & Laboratory Medicine Division, Hebei Yanda Lu Daopei Hospital, Langfang, China
2Beijing Lu Daopei Institute of Hematology, Molecular Medicine Center, Beijing, China
3Precision Medicine Center, Beijing Gene Profile Research Institute, Beijing, China
4Geneus Technologies (Chengdu) Co.,Ltd, Chengdu, China
5Department of Clinical Laboratory, Hebei Yanda Lu Daopei Hospital, Langfang, China
6Department of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China
7Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, AL, China
8Division of Pathology & Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China
9Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China
10Department of Oncology, Capital Medical University, Beijing, China

Emmi Jokinen1,2,3*, Brittany Ford, M.Sc1,2,3*, Jani Huuhtanen, MD, PhD1,3,4*, Sofia Forstén, M.Sc1,2,3*, Jay Klievink, M.Sc2,3,5*, Gabriella Antignani, M.Sc2,3,6,7*, Oscar E. Brück, MD, PhD8*, Vincenzo Cerullo2,3,6,7*, Karita Peltonen, PhD1,2,3* and Satu Mustjoki, MD, PhD1,3,4

1Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
2iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
3Translational Immunology Research Program, University of Helsinki, Helsinki, Finland
4ICAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
5Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, FIN
6Drug Research Program, ImmunoViroTherapy Lab, University of Helsinki, Helsinki, Finland
7Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
8Hematoscope Lab, Comprehensive Cancer Center & Center of Diagnostics, Helsinki University Hospital & University of Helsinki, Helsinki, Finland

Mattia Delleani1*, Saverio D'Amico, MSc1,2*, Elisabetta Sauta, PhD1*, Gianluca Asti, MSc1*, Elena Zazzetti, MSc1*, Alessia Campagna1*, Luca Lanino, MD3, Giulia Maggioni, MD1*, Maria Chiara Grondelli, BSc4*, Alessandro Forcina Barrero, BSc4*, Pierandrea Morandini, MEng1*, Marta Ubezio, MD1*, Gabriele Todisco, MD4,5*, Antonio Russo, MD1*, Cristina Astrid Tentori, MD1*, Alessandro Buizza6*, Arturo Bonometti, MD1,4*, Cesare Lancellotti, MD7*, Luca Di Tommaso, MD1,4*, Daoud Rahal, MD1*, Marilena Bicchieri, PhD1*, Victor Savevski, MEng1*, Armando Santoro, MD6*, Valeria Santini8*, Francesc Sole, PhD9, Uwe Platzbecker, MD10, Pierre Fenaux, MD11, Maria Diez-Campelo, MD, PhD12*, Rami S. Komrokji, MD13, Guillermo Garcia-Manero, MD14, Torsten Haferlach, MD15, Shahram Kordasti, MD, PhD16,17, Amer M. Zeidan, MD18, Gastone Castellani, PhD19* and Matteo Giovanni Della Porta, MD1,4*

1IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
2Train s.r.l., Rozzano, Milan, Italy
3IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy
4Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
5IRCCS Humanitas Research Hospital, Houston, TX
6IRCCS Humanitas Research Hospital, Rozzano, Italy
7Struttura Complessa di Anatomia Patologica, Policlinico di Modena, Modena, Italy
8MDS UNIT, DMSC, Azienda Ospedaliero-Universitaria Careggi & University of Florence, Florence, Italy
9Myelodysplastic Syndromes Research Group, Institut De Recerca Josep Carreras, Badalona, Barcelona, Spain
10Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
11Département (DMU) d'hématologie et immunologie, Service d'hématologie séniors, AP-HP Hospital Saint-Louis, Paris, France
12Department of Hematology, Salamanca-IBSAL University Hospital, Salamanca, Spain
13Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
14Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
15MLL Munich Leukemia Laboratory, Munich, Germany
16Hematology Unit, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Ancona, Italy
17Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
18Yale School of Medicine, Smilow Cancer Hospital at Yale New Haven, New Haven, CT
19Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy

Gianluca Asti, MSc1*, Nico Curti, PhD2*, Giulia Maggioni, MD1*, Gianluca Carlini, PhD3*, Luca Lanino, MD4, Alessia Campagna, MD1*, Saverio D'Amico, MSc1,5*, Elisabetta Sauta, PhD1*, Mattia Delleani1*, Arturo Bonometti, MD1*, Cesare Lancellotti, MD6*, Daoud Rahal, MD1*, Marta Ubezio, MD1*, Gabriele Todisco, MD7,8*, Cristina Astrid Tentori, MD1*, Antonio Russo, MD1*, Alessandra Crespi, MD1*, Giulia Figini, MD1*, Alessandro Buizza9*, Elena Riva, PhD4*, Matteo Zampini, PhD4*, Matteo Brindisi4,10*, Francesca Ficara, PhD1,10*, Laura Crisafulli, PhD4,10*, Denise Ventura, MSc4*, Nicole Pinocchio, MSc4*, Elena Zazzetti, MSc1*, Marilena Bicchieri, PhD1*, Maria Chiara Grondelli, BSc8*, Alessandro Forcina Barrero, BSc8*, Victor Savevski, MEng1*, Armando Santoro, MD8,9*, Valeria Santini, MD11, Francesc Sole, PhD12, Uwe Platzbecker, MD13, Pierre Fenaux, MD14, Maria Diez-Campelo, MD, PhD15*, Rami S. Komrokji, MD16, Torsten Haferlach, MD17, Shahram Kordasti, MD, PhD18,19, Luca Di Tommaso, MD1,8*, Amer M. Zeidan, MD20, Sanam Loghavi, MD21, Guillermo Garcia-Manero, MD22, Gastone Castellani, PhD23* and Matteo Giovanni Della Porta, MD1,8*

1IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
2Department of Physics and Astronomy, University of Bologna, Bologna, Italy
3Data Science and Bioinformatics Laboratory, IRCCS Institute of Neurological Sciences of Bologna, Bologna, Italy
4IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy
5Train s.r.l., Rozzano, Milan, Italy
6Struttura Complessa di Anatomia Patologica, Policlinico di Modena, Modena, Italy
7IRCCS Humanitas Research Hospital, Houston, TX
8Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
9IRCCS Humanitas Research Hospital, Rozzano, Italy
10Institute for Genetic and Biomedical Research, Milan Unit, CNR, Milan, Italy
11MDS Unit, Hematology, AOUC, University of Florence, Florence, Italy
12Myelodysplastic Syndromes Research Group, Institut De Recerca Josep Carreras, Badalona, Barcelona, Spain
13Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
14Département (DMU) d'hématologie et immunologie, Service d'hématologie séniors, AP-HP Hospital Saint-Louis, Paris, France
15Department of Hematology, Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain
16Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
17MLL Munich Leukemia Laboratory, Munich, Germany
18Hematology Unit, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Ancona, Italy
19Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
20Yale School of Medicine, Smilow Cancer Hospital at Yale New Haven, New Haven, CT
21Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
22Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
23Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy

Dan Tian1*, Jun Zhang2*, Yuanyuan Zhu, PhD3*, Weijia Huang4*, Jin Zhang5*, He Huang, MD6,7,8,9,10,11,12*, Xinhui Su2* and Jie Sun6*

1The first Affiliated Hospital, medical college of zhejiang Universtiy, hangzhou, China
2Department of Nuclear Medicine, the first affiliated hospital, medical college, zhejiang university, hangzhou, China
3The First Affiliated Hospital, Zhejiang University School of Medicine, HANGZHOU, CHN
4Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, HangZhou, China
5Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, hangzhou, China
6Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
7Liangzhu Laboratory, Zhejiang University Medical Center, HangZhou, China
8Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, hangzhou, China
9Institute of Hematology, Zhejiang University, Hangzhou, China
10Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University, Hangzhou, China
11Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
12Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China

Spencer Krichevsky, MS1,2*, Yuwei Zhang, MS2*, Madhu M Ouseph, MD, MBBS, PhD3*, Tahmeena Ahmed, MBBS4*, Ghaith Abu-Zeinah, MD5, Joseph M. Scandura, MD, PhD6 and Rajarsi Gupta, MD, PhD2*

1Richard T. Silver, M.D. Myeloproliferative Neoplasms (MPN) Center, Weill Cornell Medicine, New York, NY
2Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY
3Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
4Department of Pathology, Stony Brook Medicine, Stony Brook, NY
5Weill Cornell Medicine, New York, NY
6Richard T. Silver, MD Myeloproliferative Neoplasms Center, Weill Cornell Medicine, New York, NY

Sami B. Kanaan1*, Mark A Mendoza2*, Rula Gladden, MD3, Everett Fan3*, Shruti Bhise4*, Monica Thakar, MD4,5, Jeffrey Stevens6*, Soheil Meshinchi, MD, PhD7,8 and Scott N Furlan, MD7,8,9*

1Fred Hutchinson Cancer Research Center, Seattle, WA
2FRED HUTCHINSON CANCER RESEARCH CENTER, Seattle
3Fred Hutch Cancer Center, Seattle
4Fred Hutchinson Cancer Center, Seattle, WA
5Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Children's Hospital, Seattle, WA
6Seattle Children's Hospital, seattle
7Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
8Department of Pediatrics, University of Washington, Seattle, WA
9Department of Pediatrics, University of Washington, Mill Creek, WA

Shruti Sridhar1*, Michal Marek Hoppe1*, Patrick Jaynes1*, Gayatri Kumar2*, Siddham Jasoria3*, Ziwei Meng4*, Yanfen Peng1*, Sanjay De Mel, BSc, FRCPath, MRCP5,6*, Limei Poon5,6*, Esther Hian Li Chan5,6*, Wee-Joo Chng1,5,6,7, Soo Yong Tan5,8*, Susan Swee-Shan Hue5,8*, Siok-Bian Ng1,5,8*, Chandramouli Nagarajan9*, Nicholas Francis Grigoropoulos9*, Shaoying Li10*, Joseph D. Khoury11, Pedro Farinha12, Anja Mottok12*, David W. Scott, MBChB, PhD12, Xiaofei Ye13*, Qiang Pan-Hammarström14*, Vaibhav Rajan4*, Kasthuri Kannan2* and Anand Devaprasath D. Jeyasekharan, MBBS, MRCP, PhD1,5,6,7*

1Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
2Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Birla Institute of Technology & Science, Pilani, Pilani, India
4Department of Information Systems and Analytics, School of Computing, National University of Singapore, Singapore, Singapore
5NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
6Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore
7Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
8Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
9Department of Haematology, Singapore General Hospital, Singapore, Singapore
10Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
11Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
12BC Cancer Research Centre, Vancouver, BC, Canada
13Kindstar Global Precision Medicine Institute, Wuhan, China
14Division of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

Stephen Lam, PhD, MBBS,1*, Andrew Chung-Hin Poon2*, Koon C. Chan1,2*, Navrose Kaur Singh2*, Wing Lam3*, Ching-Man Wong1*, Chi Yeung Fung1*, Wing-Hei Lai1*, Ka Lam Nelson K. L. Ng, PhD1,4* and Anskar Y.H. Leung, MD, PhD1,2,5

1Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
2Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong, China
3Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong
4Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong, Hong Kong
5The Jockey Club Centre for Clinical Innovation and Discovery, The University of Hong Kong, Hong Kong, China

Seung Ah Yahng, MD, PhD1,2*, Hye Joung Kim, choicekhj@korea.ac.kr3*, Seul Bee Lee4*, Seo-hee Yoo3*, Jae-Ho Yoon, MD, PhD5,6,7,8 and Jong Hyuk Lee, MD9*

1Incheon St. Mary's Hospital, the Catholic University of Korea, Incheon, KOR
2Department of Hematology, Incheon St. Mary's Hospital, the Catholic University of Korea, Incheon, South Korea
3Korea University, Seoul, Korea, Republic of (South)
4Catholic University, Seoul, Korea, Republic of (South)
5Department of Hematology, Seoul St. Mary’s Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
6Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
7Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
8Catholic Blood and Marrow Transplantation Center, Division of Hematology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
9Hematology, Incheon St.Mary’s Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea, Republic of (South)

Alexander Fuglkjær, MSc1*, Deniz Kenan Kilic, PhD1*, Mathias Holmsgaard Eskesen, MD2,3*, Laurids Østergaard Poulsen, MD, PhD,2,3*, Carsten Utoft Niemann, MD, PhD4,5*, Paw Jensen, MD, PhD3,6*, Kirstine Kobberøe Søgaard, MD, PhD7*, Mikkel Werling, MSc8*, Frederik Christensen, MSc1*, Mikkel Runason Simonsen, MSc6*, Izabela Ewa Nielsen, MSc, PhD1* and Tarec Christoffer El-Galaly, MD, DMSc, Prof3,6

1Operations Research Group, Department of Materials and Production, Aalborg University, Aalborg, Denmark
2Department of Oncology, Aalborg University Hospital, Aalborg, Denmark
3Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
4Department of Clinical Medicine, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark
5Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
6Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
7Department of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark
8Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark

Carlos Pérez Míguez1,2*, Jose Angel Diaz Arias1,3*, Jose Antonio Taibo Salorio4*, Davide Crucitti5,6*, Manuel Piñeiro Fiel5,6*, Jesús Gómez Fernández5,6*, Noelia Jorge Ríos1,7*, Rosanna Abal García1,7* and Adrian Mosquera Orgueira, MD, PhD1,8*

1Computational Hematology & Genomics Group (GrHeCo-Xen), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
2Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain
3University Hospital of Santiago de Compostela, Department of Hematology, IDIS, A Coruña, Spain
4EDISA, Ourense, Spain
5University Hospital of Santiago de Compostela, Department of Hematology, Santiago de Compostela, Spain, Santiago de Compostela, Spain
6Computational Hematology & Genomics Group (GrHeCo-Xen), Health Research Institute of Santiago de Compostela (IDIS), Spain, Santiago de Compostela, Spain
7University Hospital of Santiago de Compostela, Department of Hematology, Santiago de Compostela, Spain
8University Hospital of Santiago de Compostela, Department of Hematology, IDIS, SANTIAGO DE COMPOSTELA, Spain

Thomas J. Gracie, MD1*, Yash Pershad2*, Cosmin Bejan3*, Alexander G. Bick, MD, PhD4*, P. Brent Ferrell, MD4 and Ashwin Kishtagari, MBBS5,6

1Internal Medicine Residency, Vanderbilt University Medical Center, Nashville, TN
2School of Medicine, Vanderbilt University Medical Center, Nashville, TN
3Vanderbilt University Medical Center, Nashville, TN
4Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
5Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Franklin, TN
6Department of Internal Medicine, Division of Hematology, Vanderbilt University School of Medicine; Ingram Cancer Center, Nashville, TN

Vahid Mehrtash, MD1*, Bita Jafarzadeh, MD2*, Dan Yoon, MS2,3*, Nicholas Ward, MD4*, Cynthia Liu, MD, PhD5*, Arnaldo Arbini5* and Christopher Y. Park, MD, PhD6

1NYU Langone Health, CLEVELAND, OH
2Department of Pathology, New York University School of Medicine, New York, NY
3Seoul National University, New York, NY
4New York University School of Medicine, New York, NY
5NYU Langone Medical Center, New York, NY
6Department of Pathology, NYU Langone School of Medicine, New York, NY

Menna Shamma1*, Elena Zheleznyakova2*, Jane Chalker3*, Jamshid Khorashad4* and Sanjay Tewari5

1Department of Paediatric Oncology, The Royal Marsden Hospital NHS Trust, Sutton, ENG, United Kingdom
2Department of Molecular Pathology, The Royal Marsden Hospital NHS trust, Sutton, United Kingdom
3Department of Molecular Pathology, Royal Marsden NHS Foundation Trust, London, United Kingdom
4Department of Molecular Pathology, The Royal Marsden Hospital NHS Trust, Sutton, United Kingdom
5Department of Paediatric Oncology, The Royal Marsden Hospital NHS Trust, Sutton, GBR

Anastasia Radko, MSc1*, Taekyoung Kwak, PhD1*, Andrey V Shubin, PhD1*, Ilya E. Krauz, MSc1*, Aleksandr Zaitsev, MS1*, Anastasiia G Tarabarova, MSc1*, Maria Savchenko, MSc1*, Mark Meerson, MSc1*, Evgenii S Bolshakov, PhD1*, Diana Lupova, MSc1*, Nika Lugovykh, MSc1*, Daniil Nikitin, MD1*, Tatiana Pashkovskaia, MSc1*, Nicholas R. Merriam, BSc1*, Mary N Abdou, BSc1*, Irina Zheleznyak, BSc1*, Kseniia L Markova, PhD1*, Anna Kersilova, MD1*, Anastasiya Yudina, MSc1*, Boris Shpak, MSc1*, Anna Kamysheva, MSc1*, Anastasiya Terenteva, PharmD1*, Nathan Fowler, MD1, Anna B Rider, BSc2*, Abner Louissaint Jr., MD, PhD3* and Michael G Goldberg, PhD1*

1BostonGene, Corp., Waltham, MA
2Department of Pathology, Massachusetts General Hospital, Boston, MA
3Massachusetts General Hospital, Boston, MA

Nina Barretts1,2*, Rebecca Turk-MacLeod, Ph.D.1*, Nima Sarshar, Ph.D.1* and Ali Kabiri3*

1CellsBin Inc., New Haven, CT
2University of New Haven, New Haven
3Cellsbin, New Haven, CT

Oona Rinkinen, MSc1*, Laura Toivanen, BSc1*, Kimmo Porkka, MD, PhD1,2,3,4,5 and Oscar E. Brück, MD, PhD1*

1Hematoscope Lab, Comprehensive Cancer Center & Center of Diagnostics, Helsinki University Hospital, Helsinki, Finland & Department of Oncology, University of Helsinki, Helsinki, Finland
2Translational Immunology Research Program, University of Helsinki, Helsinki, Finland
3Helsinki University Central Hospital Cancer Center, Helsinki, FIN
4Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
5Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

Spencer Krichevsky, MS1*, Madhu M Ouseph, MD, MBBS, PhD2*, Yuwei Zhang, MS1*, Tahmeena Ahmed, MBBS3*, Ghaith Abu-Zeinah, MD4, Joseph M. Scandura, MD, PhD5 and Rajarsi Gupta, MD, PhD1*

1Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY
2Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
3Department of Pathology, Stony Brook Medicine, Stony Brook, NY
4Richard T. Silver, MD Myeloproliferative Neoplasms Center, Weill Cornell Medicine, New York, NY
5Richard T. Silver, MD Myeloproliferative Neoplasms Center, Leukemia Program, New York, NY

Zhaozhao Chen, Doctor1,2*, Anqi Ren, Master1,3*, Hekuan Huang, Bachelor3,4*, Yingying Li5,6*, Jinhui Shu, Master4,5*, Yu Hu5,6* and Heng Mei, md, phd4,7*

1Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 中国, China
2Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, CHN
3Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China
5Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
6Hubei Clinical and Research Centre of Thrombosis and Haemostasis, Wuhan, China
7Union Hospital, Tongji Medical College, HUST, Wuhan, China

Onima Chowdhury, MD, DPhil1, Kristian Gurashi, PhD2*, Amy Wood3*, Ivan Lukic, PhD4*, Adam Sciambi, PhD4*, Lynn Quek, MD, Ph.D.5*, Daniel H Wiseman, MB ChB PhD MRCP FRCPath6* and Adam J Mead, PhD, MRCP, FRCPath7

1Oxford University Hospitals, Oxford, United Kingdom
2Medical Research Council (MRC) Weatherall Institute of Molecular Medicine, National Institute for Health Research Biomedical Research Centre, United Kingdom, University of Oxford, Oxford, United Kingdom
3Weatherall Institute of Molecular Medicine, Oxford, United Kingdom
4Mission Bio, South San Francisco, CA
5Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom
6Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom
7Medical Research Council (MRC) Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, Oxford, United Kingdom

Wenjun Zhu, MD, PhD1*, Conor Kelly, MSc2*, Keyvan Keyvanfar3*, Pradeep Dagur, PhD4* and Stefan Cordes, MD, PhD5

1Thoracic and GI Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD
2Georgetown University School of Medicine, Washington, DC
3National Heart Lung and Blood Institutes, National Institutes of Health, Bethesda, MD
4Flow Cytometry Core, National Heart Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD
5Translational Stem Cell Biology Branch, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

*signifies non-member of ASH